Company Quest PharmaTech Inc. Other OTC

Stocks

QPTFF

CA74836M1068

Biotechnology & Medical Research

Business description: Quest PharmaTech Inc.

Sales by Activity: Quest PharmaTech Inc.

Executive Committee: Quest PharmaTech Inc.

Composition of the Board of Directors: Quest PharmaTech Inc.

Shareholders: Quest PharmaTech Inc.

Company details: Quest PharmaTech Inc.

Other Biotechnology & Medical Research

Sector

Inactive Instrument

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuestâ€™s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)

See all business segments

Manager	Title	Age	Since
Ragupathy Madiyalakan CEO	Chief Executive Officer	-	2004-06-16
Pierre Vermette DFI	Director of Finance/CFO	-	2004-12-31

See QUEST PHARMATECH INC. governance

Director	Title	Age	Since
Ragupathy Madiyalakan BRD	Director/Board Member	-	2004-06-16
J. Lievonen CHM	Chairman	-	2021-07-04
Jeffrey Shon BRD	Director/Board Member	-	2021-07-04
Bradley J Glass BRD	Director/Board Member	-	-

Composition of the Board of Directors

Name	Stocks	%	Valuation
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. 14.78 %	25,000,000	14.78 %	550 000 $
Ragupathy Madiyalakan 1.892 %	3,200,000	1.892 %	70 400 $
Pierre Vermette 1.042 %	1,761,518	1.042 %	38 753 $
Jeffrey Shon 0.2069 %	350,000	0.2069 %	7 700 $
J. Lievonen 0 %	0	0 %	- $

List of QUEST PHARMATECH INC. shareholders

Quest PharmaTech, Inc.

97 Street NW

T6E 5R9, Edmonton

http://www.questpharmatech.com

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.70%	+6.89%	+2.76%	+7.65%	49.15B
REVOLUTION MEDICINES, INC.	+0.92%	+6.21%	+408.85%	+607.44%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+11.06%	+25.75%	-7.89%	34.55B
BEONE MEDICINES AG	+2.38%	+8.10%	+21.83%	+66.94%	33.09B
CELLTRION, INC.	+3.96%	+6.07%	+14.14%	+37.68%	25.19B
ASCENDIS PHARMA A/S	+2.51%	+4.94%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+7.24%	+71.03%	+132.17%	15.92B
EUROFINS SCIENTIFIC SE	+0.32%	+1.58%	+14.34%	+19.26%	13.83B
ICON PUBLIC LIMITED COMPANY	-1.14%	+7.52%	+14.75%	-30.83%	13.26B
Average	+1.68%	+5.99%	+71.68%	+104.05%	26.92B
Weighted average by Cap.	+1.81%	+6.31%	+89.14%	+131.73%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research